Key facts
- This page summarizes Christopher Downs's Form 4 filing for CNS Pharmaceuticals, Inc. (CNSP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 14 Mar 2022, 09:40.
Christopher Downs - 11 Mar 2022 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)
- Signature
- /s/ Christopher Downs
- Issuer symbol
- CNSP
- Transactions as of
- 11 Mar 2022
- Net transactions value
- +$10,230
- Form type
- 4
- Filing time
- 14 Mar 2022, 09:40:12 UTC
- Previous filing
- 11 Feb 2022
- Next filing
- 29 Apr 2022
- SEC
- View on sec.gov
Key filing fact
Christopher Downs filed Form 4 for CNS Pharmaceuticals, Inc. (CNSP) on 14 Mar 2022.
Change
- Previous filing in this sequence was filed on 11 Feb 2022.
- Current net transaction value: +$10,230.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
CNSP
transaction
Common Stock
Award
- Transaction value
- $10,230
- Shares
- +33,000
- Change %
- +22%
- Price
- $0.3100
- Shares after
- 184,500
- Date
- 11 Mar 2022
- Ownership
- Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.